Phase
Condition
Myelofibrosis
Leukemia
Neoplasms
Treatment
Education Control
Telehealth Serious Illness Care Program
Clinical Study ID
Ages > 60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion and Exclusion Criteria for Patients
Inclusion criteria:
Age ≥60 years
A diagnosis of AML, MDS, and similar myeloid malignancies (including but not limitedto MDS/MPN overlap syndrome, myelofibrosis)
Being managed in the outpatient settings
Able to provide informed consent
English-speaking
Exclusion
Exclusion criteria:
- None
Inclusion and Exclusion Criteria for Caregivers
Inclusion criteria:
Age ≥18 years
Selected by patient when asked if there is a "family member, partner, friend, orcaregiver with whom you discuss or who can be helpful in health-related matters"
Able to provide informed consent
English-speaking
Exclusion criteria:
- None
Inclusion and Exclusion Criteria for Oncology Providers
Inclusion criteria:
- Oncologists and/or APPs who will be conducting the telehealth-delivered ACP visit
Exclusion criteria:
- None
Study Design
Study Description
Connect with a study center
University of Rochester
Rochester, New York 14642
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.